{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:34:29Z","timestamp":1793399669717,"version":"4.5.0"},"reference-count":42,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2002,8,29]],"date-time":"2002-08-29T00:00:00Z","timestamp":1030579200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2002,9]]},"abstract":"<jats:p><jats:bold>Summary.\u2002<\/jats:bold>We studied the effectiveness of risk\u2010directed therapy for infants younger than 13\u2003months of age with acute lymphoblastic leukaemia (ALL). Fifty\u2010five infants were assigned to different treatment programs (from December 1995 to December 1998) on the basis of their<jats:italic>MLL<\/jats:italic>gene status at diagnosis. Forty\u2010two cases (76\u00b73%) had a rearranged<jats:italic>MLL<\/jats:italic>gene (<jats:italic>MLL<\/jats:italic><jats:sup>+<\/jats:sup>) and were treated with remission induction therapy followed by sequential intensive chemotherapy, including multiple genotoxic agents (MLL9601 protocol). Haematopoietic stem cell transplantation (HSCT) was attempted if suitable donors were available. Thirteen infants (23\u00b77%) were classified as<jats:italic>MLL<\/jats:italic><jats:sup>\u2013<\/jats:sup>and treated for 2\u00b75\u2003years with intensive chemotherapy for high\u2010risk B\u2010ALL (MLL9602 protocol). Complete remission was induced in 38 of the 42 infants (90\u00b75%) with<jats:italic>MLL<\/jats:italic><jats:sup>+<\/jats:sup>ALL and in all 13 patients (100%) with<jats:italic>MLL<\/jats:italic><jats:sup>\u2013<\/jats:sup>disease. In the<jats:italic>MLL<\/jats:italic><jats:sup>+<\/jats:sup>subgroup, the estimated event\u2010free survival (EFS) rate at 3\u2003years post diagnosis was 34\u00b70%\u2003\u00b1\u20037\u00b75%, compared with 92\u00b73%\u2003\u00b1 7\u00b74% in the<jats:italic>MLL<\/jats:italic><jats:sup>\u2013<\/jats:sup>subgroup (overall comparison,<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b7001 by log\u2010rank analysis). Both age less than 6\u2003months (hazard ratio\u2003=\u20036\u00b787, 95% CI\u2003=\u20030\u00b791\u201352\u00b73;<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b7013) and central nervous system (CNS) involvement at diagnosis (hazard ratio\u2003=\u20032\u00b792 95% CI\u2003=\u20031\u00b729\u20136\u00b763;<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b7015) were significant independent predictors of an inferior outcome. These findings indicate a strategic advantage in classifying infant ALL as either<jats:italic>MLL<\/jats:italic><jats:sup>+<\/jats:sup>or<jats:italic>MLL<\/jats:italic><jats:sup>\u2013<\/jats:sup>early in the clinical course and selecting therapy accordingly. Standard chemotherapy for high\u2010risk B\u2010lineage ALL appeared adequate for<jats:italic>MLL<\/jats:italic><jats:sup>\u2013<\/jats:sup>cases. Novel therapeutic initiatives are warranted for infants with<jats:italic>MLL<\/jats:italic><jats:sup><jats:italic>+<\/jats:italic><\/jats:sup>disease, particularly those with initial CNS leukaemic involvement or age less than 6\u2003months, or both.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2002.03754.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:47:35Z","timestamp":1047365255000},"page":"999-1010","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Risk\u2010directed treatment of infant acute lymphoblastic leukaemia based on early assessment of<i>MLL<\/i>gene status: results of the Japan Infant Leukaemia Study (MLL96)"],"prefix":"10.1111","volume":"118","author":[{"given":"Keiichi","family":"Isoyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeyoshi","family":"Hibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Kinukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroji","family":"Ohkawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Kawasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Kosaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin\u2010ichiro","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhide","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taijiro","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masue","family":"Imaizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuki","family":"Mizutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Tsukimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanao","family":"Kamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichi","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,8,29]]},"reference":[{"key":"e_1_2_17_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1997.tb00399.x"},{"key":"e_1_2_17_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng765"},{"key":"e_1_2_17_4_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199409051677"},{"key":"e_1_2_17_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.7.2870.bloodjournal8772870"},{"key":"e_1_2_17_6_1","doi-asserted-by":"publisher","DOI":"10.1159\/000133612"},{"key":"e_1_2_17_7_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1033706"},{"key":"e_1_2_17_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V81.9.2386.2386"},{"key":"e_1_2_17_9_1","first-page":"1275","article-title":"Acute lymphoblastic leukaemia in infancy: experience in MRC UKALL trials","volume":"8","author":"Chessells J.M.","year":"1994","journal-title":"Leukemia"},{"key":"e_1_2_17_10_1","first-page":"6712","article-title":"Cloning of ALL\u20101, the locus involved in leukemias with the t(4;11)(p21;q23), t(9;11)(p22;q23), and t(11;19)(q23;p13) chromosome translocations","volume":"51","author":"Cimino G.","year":"1991","journal-title":"Cancer Research"},{"key":"e_1_2_17_11_1","first-page":"391","article-title":"Prognostic relevance of ALL\u20101 gene rearrangement in infant acute leukemias","volume":"9","author":"Cimino G.","year":"1995","journal-title":"Leukemia"},{"key":"e_1_2_17_12_1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables","volume":"34","author":"Cox D.R.","year":"1972","journal-title":"Journal of the Royal Statistical Society"},{"key":"e_1_2_17_13_1","volume-title":"B.M.D.P. Statistical Software Manual","author":"Dixon W.J.","year":"1992"},{"key":"e_1_2_17_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.4.1209"},{"key":"e_1_2_17_15_1","first-page":"313","article-title":"Treatment of infant leukemia with busulfan, cyclophosphamide + etoposide and bone marrow transplantation","volume":"9","author":"Emminger W.","year":"1992","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_17_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb04727.x"},{"key":"e_1_2_17_17_1","first-page":"372","article-title":"Infant leukemia biology, aetiology and treatment","volume":"10","author":"Greaves M.F.","year":"1996","journal-title":"Leukemia"},{"key":"e_1_2_17_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V83.8.2274.2274"},{"key":"e_1_2_17_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.10.3876.bloodjournal86103876"},{"key":"e_1_2_17_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950190106"},{"key":"e_1_2_17_21_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1442-200x.1999.01113.x"},{"key":"e_1_2_17_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1958.10501452"},{"key":"e_1_2_17_23_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.18.3256"},{"key":"e_1_2_17_24_1","first-page":"1299","article-title":"Detection of 11q23\/MLL rearrangements in infant leukemias with fluorescence in situ hybridization and molecular analysis","volume":"9","author":"Martinez\u2010Climent J.A.","year":"1995","journal-title":"Leukemia"},{"key":"e_1_2_17_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401512"},{"key":"e_1_2_17_26_1","volume-title":"An International System for Human Cytogenetic Nomenclature","author":"Mitelman F.","year":"1995"},{"key":"e_1_2_17_27_1","first-page":"224","article-title":"Treatment of infant acute lymphoblastic leukemia in Japan","volume":"69","author":"Nishimura S.","year":"1999","journal-title":"International Journal of Hematology"},{"key":"e_1_2_17_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401129"},{"key":"e_1_2_17_29_1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1200\/JCO.1996.14.1.4","article-title":"Selecting treatment for children with acute lymphoblastic leukemia","volume":"14","author":"Pinkel D.","year":"1996","journal-title":"Journal of Clinical Oncology"},{"key":"e_1_2_17_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-911X(199901)32:1<1::AID-MPO2>3.0.CO;2-J"},{"key":"e_1_2_17_31_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199808273390907"},{"key":"e_1_2_17_32_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1994.12.5.909"},{"key":"e_1_2_17_33_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1985.3.11.1513"},{"key":"e_1_2_17_34_1","first-page":"1033","article-title":"Improved survival of infants less than 1 year of age with acute lymphoblastic leukemia treated with intensive multiagent chemotherapy","volume":"71","author":"Reaman G.H.","year":"1987","journal-title":"Cancer Treatment Reports"},{"key":"e_1_2_17_35_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.2.445"},{"key":"e_1_2_17_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(97)00051-9"},{"key":"e_1_2_17_37_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.2.570.570"},{"key":"e_1_2_17_38_1","first-page":"74","article-title":"11q23 rearrangements in acute leukemia","volume":"10","author":"Rubnitz J.E.","year":"1996","journal-title":"Leukemia"},{"key":"e_1_2_17_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19971215)80:12<2285::AID-CNCR10>3.0.CO;2-Q"},{"key":"e_1_2_17_40_1","first-page":"1303","article-title":"Frequency and clinical significance of the MLL gene rearrangements in infant acute leukemia","volume":"10","author":"Taki T.","year":"1996","journal-title":"Leukemia"},{"key":"e_1_2_17_41_1","first-page":"810","article-title":"Clinical significance of MLL \u2013AF4 fusion transcript expression in the absence of a cytogenetically detectable t(4;11)(q21;q23) chromosomal translocation","volume":"92","author":"Uckun F.M.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_17_42_1","first-page":"479","article-title":"Gene rearrangement and truncated mRNA in cell lines with 11q23 translocation","volume":"8","author":"Yamamoto K.","year":"1993","journal-title":"Oncogene"},{"key":"e_1_2_17_43_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.23.10735"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2002.03754.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2002.03754.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2002.03754.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T19:51:50Z","timestamp":1733773910000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2002.03754.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8,29]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,9]]}},"alternative-id":["10.1046\/j.1365-2141.2002.03754.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2002.03754.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,8,29]]},"assertion":[{"value":"2002-08-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}